![Josh Mandel-Brehm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Josh Mandel-Brehm
Chief Executive Officer at
CAMP4 THERAPEUTICS CORPORATION
Net worth: 1 M $ as of 30/05/2026
Profile
Josh Mandel-Brehm is the founder of Vico Therapeutics BV, founded in 2019, serving as Director since its founding.
Current jobs include President, Chief Executive Officer & Director at CAMP4 Therapeutics Corp.
since 2017, and Independent Director at ProMIS Neurosciences, Inc. since 2021.
Former job includes Partner at Polaris Growth Management LLC from 2017 to 2021.
Education includes undergraduate studies at Washington University in St. Louis and an MBA from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 278,417 ( 0.59% ) | 1 M $ | 30/05/2026 | |
| 19/05/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Josh Mandel-Brehm active positions
| Companies | Position | Start |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Chief Executive Officer | 30/04/2017 |
| PROMIS NEUROSCIENCES, INC. | Director/Board Member | 31/08/2021 |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Founder | 31/12/2018 |
Former positions of Josh Mandel-Brehm
| Companies | Position | End |
|---|---|---|
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Corporate Officer/Principal | 30/09/2021 |
Training of Josh Mandel-Brehm
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaris Growth Management LLC
Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Finance |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Health Technology |
- Stock Market
- Insiders
- Josh Mandel-Brehm
